A continuous-flow centrifuge was used to infuse sodium salts of oleic, linoleic, lauric, or palmitic acid into the pancreatic artery of anesthetized dogs. In these regional perfusion studies there was no increase in FFA levels in the general circulation. Elevation of pancreatic FFA levels produced an immediate increase in pancreatic venous immunoreactive insulin (IRI). After 10 min of FFA infusion. IRI levels declined somewhat from the initial peak response but soon rose again to high levels which were then sustained until the infusion was terminated. All four long-chain FFA tested produced a similar biphasic IRI response. Clearcut increases in IRI were associated with absolute FFA levels (measured in pancreaticoduodenal venous plasma) as low as 0.6-0.8 µeq/ml and with increments over basal levels of as little as 0.4-0.5 µeq/ml. At higher levels of FFA, absolute IRI levels in the pancreatic venous effluent exceeded 1,000 µU/ml in some experiments and 5-to 10-fold increases over basal values were observed.
A B S T R A C T A continuous-flow centrifuge was used to infuse sodium salts of oleic, linoleic, lauric, or palmitic acid into the pancreatic artery of anesthetized dogs. In these regional perfusion studies there was no increase in FFA levels in the general circulation. Elevation of pancreatic FFA levels produced an immediate increase in pancreatic venous immunoreactive insulin (IRI). After 10 min of FFA infusion, IRI levels declined somewhat from the initial peak response but soon rose again to high levels which were then sustained until the infusion was terminated. All four long-chain FFA tested produced a similar biphasic IRI response. Clearcut increases in IRI were associated with absolute FFA levels (measured in pancreaticoduodenal venous plasma) as low as 0.6-0.8 Aeq/ml and with increments over basal levels of as little as 0.4-0.5 geq/ml. At higher levels of FFA, absolute IRI levels in the pancreatic venous effluent exceeded 1,000 AU/ml in some experiments and 5-to 10-fold increases over basal values were observed.
These studies indicate that long-chain FFA, in physiological concentrations, can markedly stimulate insulin secretion by a direct effect on the pancreas. The results lend support to the concept of insulin as a hormone that is importantly involved in regulating the metabolism of all three principal classes of metabolic substrates and whose release is in turn regulated by all of them. The relative importance and precise nature of its physiologic role in the regulation of lipolysis, lipid deposition, and ketone body formation remains to be established. (3) . These studies do not establish whether the elevated FFA levels stimulate insulin release in vivo by a direct effect on the pancreas or whether the effect is indirect (e.g., secondary to metabolic effects in the periphery, effects via other endocrine systems or effects on the nervous system). There is some evidence that FFA may stimulate insulin secretion directly in vitro (4, 5) but other investigators have reported negative results (6, 7) . In any case in order to establish physiologic significance it is still necessary to demonstrate effectiveness of FFA in vivo. In the present study, we have examined the nature of the insulin response accompanying infusion of long-chain FFA directly into the pancreatic artery of anesthetized dogs. These infusions raised intrapancreatic FFA levels without significantly increasing plasma FFA concentrations peripherally. We have also examined the sensitivity of the response and compared responses to four different fatty acids.
INTRODUCTION

METHODS
The general method for systemic infusion of FFA salts into mongrel dogs using a continuous-flow blood centrifuge
The Journal of Clinical Investigation Volume 52 August 1973 August 1979 August -1984 has been described in detail (8) . For intrapancreatic infusion it was modified as follows. After an overnight fast, each dog was anesthetized with sodium pentobarbital (30 mg/kg) and connected to a mechanical respirator. The pancreas was exposed by a mid-line laparotomy and the superior pancreaticoduodenal artery and vein were isolated. The animal was then given 5,000 U of heparin intravenously and connected by carotid artery-jugular vein shunts to the continuous-flow centrifuge' as for systemic FFA infusion.
Carotid artery blood was continuously separated into cells and plasma, initially at 100 ml/min. These components emerged from the centrifuge via separate lines, were recombined, and returned continuously to the dog via the jugular vein.
After a 15 min stabilization period on the centrifuge, the pancreaticoduodenal artery was cannulated with a medium Bard-Deseret Intracath, and two cannulas, connected by a T-fitting, were inserted into the pancreaticoduodenal vein. Thus, except during sampling, blood flowed normally from the pancreatic vein into the portal vein. The' return line from the centrifuge was then switched from the jugular vein to the pancreaticoduodenal artery and blood flow was reduced to a constant rate of 16-24 ml/min. The separated cells and plasma were recombined and infused into the pancreaticoduodenal artery at ambient arterial pressure (100-140 mm Hg) at 370C.
Sodium salts of oleic, linoleic and lauric acids were prepared as previously described for oleate (8) and diluted to 0.5-1%o with normal saline (final pH 9.4). They were then infused into the plasma line at constant rates of 0.8-1.4 ml/min (1.4-2.5 Aeq/kg per min), for 30 min. The concentrated FFA solutions did not dilute the carotid artery blood perfusing the pancreas by more than 6%, and did not significantly alter its pH. During control periods of 20' min which preceded and followed each FFA infusion, normal saline was infused into the plasma line at the same rate (ml/min) used for the FFA. Sodium palmitate for infusion was prepared by mixing equal volumes of 0.25-0.50% sodium palmitate (in 0.85%o saline) and the dog's own plasma, which had been quickly derived from the plasma line of the centrifuge during the stabilization period. In two experiments, this mixture and the control mixture-which consisted of equal volumes of saline and the same dog's plasma-were enriched with canine serum albumin (Fraction V) 2 3_4.5 g/100 ml. Infusion of KrebsRinger bicarbonate solution, pH 9.4, at 1.0 ml/min had no significant effect on insulin secretion. Pancreatic venous blood flow remained constant (±15%o) during each experiment.
Methylene blue dye infusion after each experiment revealed that a small amount of infusion mixture perfused the adjacent duodenum. To exclude the possibility that the concomitant perfusion of the duodenum affected the insulin response to intrapancreatic FFA infusion, an experiment was carried out in which sodium oleate was infused exclusively into a small area of the tail of the pancreas via the splenic artery, according to the technique of Goetz, Maney, and Greenberg (9) .
Blood was sampled from the carotid and pancreaticoduodenal arteries and from the pancreaticoduodenal vein. It was chilled immediately to 4°C and analyzed for plasma FFA, IRI, glucose, and total ketones by methods previously described (1 Table I . Again, because the FFA infusion rate was low on a whole body basis, no significant ketonemia was to be expected and spot checks verified this. Serial determinations were made in two studies and these results are shown in Table I (dogs 70 and 71).
When infusion of FFA was started, pancreatic vein FFA levels rose immediately to a new steady-state value and remained elevated until the end of the infusion (Figs. 1-3 and Table I ). Within 2-5 min after the start of the infusion (the earliest samplings taken), pancreatic IRI began to rise and reached a peak of three to six times control levels at 5-10 min. Thereafter, IRI declined somewhat but still remained markedly elevated above control levels until the end of the infusion. Often a second peak in the insulin response curve was apparent after 20-30 min of infusion (Figs. 2 and 3 and Table I ). When the infusion was terminated, pancreatic FFA and IRI levels fell quickly to control values.
The magnitude of the peak IRI response correlated roughly with the mean pancreatic FFA level reached during infusion. This is concordant with previous results using systemic infusion of FFA (1) . All four long-chain FFA tested appeared to be approximately equipotent in stimulating insulin secretion although minor quantitative differences cannot be ruled out without further study. Even modest elevation of pancreatic FFA levels, to values of 1.1 Aeq/ml or less, produced three-to fourfold increases in pancreatic IRI ( Fig. 3 When sodium oleate was infused into the splenic artery branch supplying the tail of the pancreas, in order to prevent FFA-rich blood from reaching any other abdominal viscera, marked stimulation of insulin secretion also occurred (Table I, (9) and eliminates the possibility that the observed insulin responses were secondary to FFA-stimulated release of enteric hormones known to stimulate insulin secretion (11) . Since only one study was done in this manner, this possibility cannot be ruled out but in view of the limited area of duodenum receiving FFA-enriched blood the possibility seems remote. Since peripheral arterial levels of FFA were not elevated, effects involving the action of FFA on endocrine organs, the central nervous system or the autonomic nervous system with secondary effects on the pancreas are ruled out. Thus, it is concluded that the insulin response is a direct effect of FFA on the pancreatic beta cell.
Malaisse has reported that 0.5 mM palmitate stimulated IRI release from pieces of rat pancreas (4), while others have shown that the medium-chain FFA octanoate can stimulate IRI release both in vitro and in vivo (3, 5) . However, Howell (cited in reference 6) was unable to demonstrate an effect of palmitate on rat islets, nor could Pi-Sunyer find an effect of 3 mM octanoate or oleate on insulin secretion from pieces of rat or rabbit pancreas incubated in vitro (7) . Moreover, in preliminary experiments in which a continuous-flow contrifuge was not used to perfuse the pancreas, we were unable to stimulate insulin secretion by merely infusing FFA- Systemic glucose levels fell much less in the presen studies than in previous studies using systemic FFA in fusion into conscious animals (1) even though systemi( insulin levels rose in some cases to values of 20-25 /AU/ ml. The possibility that the proinsulin to insulin ratic was increased should be considered but since the stimulus (elevated arterial FFA levels) was the same in both sets of experiments this is unlikely to explain the difference. A decrease in insulin sensitivity secondary to surgery and anesthesia may be enough to account for the dampened glucose response (10) .
The present studies extend the evidence that substrates derived from each of the three principal classes of metabolic fuels-carbohydrates, proteins, and fats-are capable of stimulating insulin release (12) . Clearly insulin is not to be considered merely a hormone regulating carbohydrate utilization and storage, but rather a hormone broadly involved in regulation of and regulation by an array of metabolic fuels (13) . The present studies also show that long-chain FFA are capable of producing a biphasic insulin response resembling that previously demonstrated for glucose and possibly amino acids (14, 15) . Grodsky, Landahl, Curry, and Bennett (16) suggested that this response represents the early release of preformed insulin granules followed by a slower phase of release related to de novo synthesis of insulin. The infusion of gastrointestinal hormones such as secretin, however, produces only uniphasic insulin responses (12, 17) .
The exact mechanism by which long-chain FFA stimulate insulin secretion is unknown. Montague and Taylor (18) reported that octanoate and citrate increased the intracellular concentrations of glucose-6-phosphate and 6-phosphogluconate in isolated rat islets incubated for 30 min. They proposed that insulin release was promoted by enhancing oxidation of glucose-6-phosphate through this pathway. Matschinsky et al. (19) , however, did not find an increase in glucose-6-phosphate or 6-phosphogluconate in rat islets exposed to glucose for less than 5 min although insulin release occurred within 1 min. They proposed that glucose plays a dual role in islet metabolism, i.e., it is both a direct chemical stimulant of the early phase of insulin secretion as well as a substrate promoting newly synthesized insulin secreted in the later phase. Long-chain FFA could conceivably also play such a dual role in islet metabolism, but the intracellular metabolism of FFA in islets remains to be elucidated. We did not detect significant conversion of FFA to ke- (20, 21) , in the pancreatic effluent blood. However, a selective conversion of FFA to ketones in only the endocrine and not in the exocrine pancreas would probably not be detected because the former comprises only a small fraction of the total pancreatic mass. Whether glucose, amino acids and fatty acids exert this effect via a common intermediate such as pyruvate or even ATP is not known (22) .
In contrast to the marked stimulation of insulin secretion that accompanies systemic or intrapancreatic infusion of FFA in dogs (1, 2) elevation of long-chain FFA levels by oral fat and heparin does not cause a significant rise in plasma insulin in dogs (1) or man (23) . The cause of this paradox is unknown but may be related metabolic effects occurring during fat digestion, absorption, or chylomicron removal. During chylomicron assimilation, small increments in insulin secretion could be undetected in peripheral plasma because of increased hepatic uptake. McCullough et al. (24) reported that stimulation of insulin secretion by medium-chain triglycerides could be demonstrated only in cirrhotics with evidence of portal-systemic communications. No increase in peripheral insulin was found in normal subjects. Thus, Stimulation of Insulin Secretion by Long-Chain Free Fatty Acids a small increase in portal insulin levels caused by longchain FFA could be masked in the periphery.
Whether long-chain FFA play a physiological role in the regulation of insulin secretion in man remains to be established. Such an effect could promote esterification of FFA during periods of feeding and inhibit lipolysis during fasting. The latter effect could represent a form of negative feedback control limiting hormone-stimulated lipolysis. It might also help maintain the low but detectable levels of insulin during fasting tending to prevent ketoacidosis (1, 2) .
